You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股開盤 | 恆指高開0.21%,再鼎醫藥-SB上市首日高開9.16%,頂頭槌大佬狂賺逾770萬

【三大指數】

香港恆生指數9月28日(週一)開盤上漲48.67點,漲幅0.21%,報23284.09點;

恆生國企指數9月28日(週一)開盤上漲43.02點,漲幅0.46%,報9345.61點;

恆生紅籌指數9月28日(週一)開盤下跌13.74點,跌幅0.38%,報3570.31點。

【新股首日】

回港二次上市的再鼎醫藥-SB首日高開9.16%,報613.5港元,上市股價即超過騰訊,成爲港股新股王。不計手續費,一手賺2575港元

與華住一樣,再鼎醫藥-SB的乙組獲配股數極高,乙頭獲配3600股,市值202.32萬港元,頂頭槌獲配150,600股,市值8463.72萬港元。不計手續費,乙頭賺逾18萬,頂頭槌大佬狂賺775萬。

《新股暗盤 | 再鼎醫藥-SB盤中一度漲超4%,頂頭槌狂賺250萬》

《新股配售 | 再鼎醫藥一手中籤率50%,公開認購3.43倍,國配6.9倍,港股比美股折價5.97%》

【異動個股】

恆大汽車漲7.02%,中國恆大漲3.05%。

中芯國際(00981.HK)跌超7%。

美團點評漲1.72%,京東漲1.56%,騰訊控股漲0.3%,小米集團漲近2%,阿里巴巴漲1.55%

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account